News
Dec 6, 2024

THIER Appoints Daniel Fincham as Independent Non-Executive Director to Drive Customer-Centric Innovation

THIER Appoints Daniel Fincham as Independent Non-Executive Director to DriveCustomer-Centric Innovation

THIER, a pioneering digital health start-up committed to preventing lifestyle-related diseases, is excited to announce the appointment of Daniel Fincham as an IndependentNon-Executive Director, effective October 25, 2024. This strategic appointment underscores THIER’s dedication to enhancing customer engagement and scaling operational success as it continues to expand in the digital health landscape.

Daniel Fincham brings a robust background in SaaS and customer success, with over 15years of experience in building and scaling digital platforms for growth-oriented brands. Most recently, as Vice President of Customer Success at Zmags, Daniel played a pivotal role in developing a digital experience platform that enabled brands to create impactful online customer experiences. With teams spanning Copenhagen, London, and Boston, he spearheaded initiatives that transformed customer engagement strategies across multiple regions.

In addition to his achievements at Zmags, Daniel is also a seasoned entrepreneur, having launched successful start-ups like Recoverlution and [ZYZ]. His experience as an NED and mentor to several start-ups highlights his dedication to supporting early-stage companies in navigating growth and scaling challenges.

Kofo Mary Are, Senior Executive at  THIER, shared her enthusiasm about Daniel’s new role on the Board:

"We are thrilled to welcome Daniel Fincham to THIER’s Board. His depth of experience in customer success and his entrepreneurial track record are exactly what we need as we drive THIER’s mission to the next level. Daniel’s insight and hands-on expertise with SaaS models will be invaluable as we expand our reach in digital health."

Daniel Fincham, "I am honoured to join the THIER board and contribute to its innovative journey. The team’s vision to prevent lifestyle diseases aligns closely with my own values, and I look forward to working with THIER to achieve its full potential."

AboutTHIER

THIER is an AI-driven mobile platform dedicated to preventing obesity and type II diabetes by equipping organisations with tools to foster healthier workplaces.Targeted towards Heads of Wellness, Heads of HR, and Heads of OccupationalHealth, THIER offers robust solutions to identify, monitor, and prevent lifestyle-related health risks in employee communities across a range of sectors, including manufacturing, healthcare, technology, financial services, energy, and transportation.

By combining machine learning algorithms, community support, and personalised health interventions from preventive healthcare specialists, THIER’s platform enables effective disease prevention. All data is securely managed on blockchain technology, ensuring transparency and data protection.

Discover more about THIER’s innovative solutions:

  • 🎥 Watch our video overview: Link to Video
  • 🤝 Interested in supporting early-stage  digital health innovation as an angel investor? Connect with us here: Investor Form

Note: THIER holds SEIS and EIS assurance, providing tax benefits for investors.

For further inquiries, please contact: THIER Communications Team
📧 Press@thier.io

·     Visit our website: www.thier.io

  • 🎥 Watch our     introductory video: Link to Video
  • 🤝 Interested in     supporting early-stage digital health innovation as an investor?
🤝 Interested in supporting early-stage digital health innovation as an investor? Connect with us here: 👈 😀

Note: THIER holds SEIS and EIS assurance, offering tax benefits for investors.

ContactInformation
THIER Communications Team
📧 Press@thier.io

***********

The information in this announcement may include forward-looking statements, which are based on the current expectations and projections about future events, and in certain cases can be identified by the use of terms such as "may","will", "should", "expect","anticipate", "project", "estimate","intend", "continue", "target","believe" (or the negatives thereon) or other variations thereon or comparable terminology.

These forward-looking statements, as well as those included in any related materials, are subject to risks, uncertainties and assumptions about the Company and/or its underlying investments, including, among other things, the development of the applicable entity's business, trends in its operating industry, expected use of financing proceeds and future capital expenditures and acquisitions. Considering these risks, uncertainties and assumptions, the events in the forward-looking statements may not occur.

The information contained in this announcement is given at the date of its publication (unless otherwise marked). No reliance may be placed for any purpose whatsoever on the information or opinions contained in this announcement or on its completeness, accuracy or fairness.

 

 

 

Subscribe to our newsletter

Thanks for joining our newsletter.
Oops! Something went wrong while submitting the form.